Boston Scientific Corp (BSX) Stock Price, Quote & News

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary syst...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 683 4000

Website: www.bostonscientific.com

Address:

300 Boston Scientific Way, Marlborough, United States

OfficialStocktwitsUser Mar. 14 at 2:31 AM

$BSX RSI: 34.91, MACD: -3.6225 Vol: 2.62, MA20: 73.45, MA50: 83.02 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

DragonAlgo Mar. 13 at 9:27 PM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-04-02 | Strike: $74.00 | Type: CALL Option Plan (premium): Entry: $1.40 Stop: $1.01 TP1: $1.82 TP2: $2.38 TP3: $3.36 🔗 https://dragonalgo.com

0 · Reply

TheBurnerAccount Mar. 13 at 6:45 PM

$BSX Today may just be opex movement. Will know next week if its holding or not before the all clear

0 · Reply

amberajax2point0 Mar. 13 at 6:32 PM

$BSX too early to tell, but she is finally showing some life.

0 · Reply

Charterdi3 Mar. 13 at 4:30 PM

$BSX $DJT $UNH Nothing at all … 😛☺️ 3month charts ‼️

0 · Reply

DragonAlgo Mar. 13 at 4:45 AM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-04-02 | Strike: $71.00 | Type: CALL Option Plan (premium): Entry: $2.10 Stop: $1.51 TP1: $2.73 TP2: $3.57 TP3: $5.04 🔗 https://dragonalgo.com

0 · Reply

REDBEAR Mar. 13 at 2:45 AM

$BSX reminds me of when I made a ton of money with $REGN going down. We will do the same here.

0 · Reply

GSTX7 Mar. 12 at 11:14 PM

$BSX Raise your hand if you're waiting for $60 to enter. 🙋

1 · Reply

TechTraderGrok Mar. 12 at 8:50 PM

Sold $BSX at $68.56 (-4.6%). From Grok: "Exiting long on BSX at 68.83 as persistent downtrend breaks below lower BB with negative MACD despite oversold RSI, compounded by Class I recall, litigation, and lowered analyst targets overriding March 28 catalyst potential." https://www.techtrader.ai/grokwall/?post=16925&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

Bazzzigar Mar. 12 at 6:06 PM

$BSX few more

0 · Reply

BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt

Mar 10, 2026, 12:42 PM EDT - 4 days ago

8 Stocks to Buy as Merger-Mania Takes Over

AVTR EPC ITGR MXL PEN POWI PRGO

Mar 8, 2026, 8:24 PM EDT - 6 days ago

BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm

Mar 6, 2026, 1:56 PM EST - 8 days ago

BOSTON SCIENTIFIC CORPORATION (BSX) INVESTOR ALERT Investors With Large Losses in Boston Scientific Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Mar 6, 2026, 8:00 AM EST - 8 days ago

Boston Scientific to host investor event at the 75th Annual Scientific Session of the American College of Cardiology

Mar 4, 2026, 9:00 AM EST - 10 days ago

Boston Scientific Corporation Investigated by the Portnoy Law Firm

Mar 3, 2026, 12:12 PM EST - 11 days ago

Boston Scientific Corporation (BSX) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Mar 3, 2026, 10:36 AM EST - 11 days ago

Baron Health Care Fund Q4 2025 Recent Activity

ACLX ARQT ELAN MASI RGEN SYK TMO

Feb 25, 2026, 1:00 PM EST - 17 days ago

Penumbra, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

PEN

Feb 23, 2026, 8:00 AM EST - 19 days ago

Boston Scientific elects Cathy Smith and Christophe Weber to Board of Directors

Feb 18, 2026, 10:47 AM EST - 24 days ago

Back on the Radar: Prior Picks Offer Fresh Opportunity

NFLX

Feb 13, 2026, 8:00 AM EST - 4 weeks ago

Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

Feb 6, 2026, 2:05 PM EST - 5 weeks ago

Reassessing The Boston Scientific Bull Thesis

Feb 5, 2026, 2:25 PM EST - 5 weeks ago

What Happened To Boston Scientific Stock?

Feb 5, 2026, 8:18 AM EST - 5 weeks ago

Boston Scientific Analysts Cut Their Forecasts Following Q4 Results

Feb 4, 2026, 3:30 PM EST - 5 weeks ago

Boston Scientific Corporation (BSX) Q4 2025 Earnings Call Transcript

Feb 4, 2026, 9:19 AM EST - 5 weeks ago

Boston Scientific Profit, Sales Rise but Issues Soft Guidance

Feb 4, 2026, 8:12 AM EST - 5 weeks ago

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply.

Feb 4, 2026, 8:02 AM EST - 5 weeks ago

Boston Scientific shares slide on cautious 2026 revenue forecast

Feb 4, 2026, 6:30 AM EST - 5 weeks ago

Boston Scientific announces results for fourth quarter and full year 2025

PEN

Feb 4, 2026, 2:02 AM EST - 5 weeks ago

Boston Scientific Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Feb 2, 2026, 5:02 PM EST - 5 weeks ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR)

Jan 29, 2026, 9:39 AM EST - 6 weeks ago

Artisan Global Opportunities Fund Q4 2025 Portfolio Update

ARGX BKR COF COIN INSM LEG LHX

Jan 26, 2026, 2:54 PM EST - 6 weeks ago

Calls of the Day: Wynn, Cummins, Boston Scientific, Applovin and Monster Beverage

APP CMI MNST WYNN

Jan 22, 2026, 12:05 AM EST - 7 weeks ago

Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity

ADBE AMZN AON MELI SAP SPOT

Jan 16, 2026, 10:00 AM EST - 2 months ago

How Low Can Boston Scientific Stock Go When Markets Turn Sour?

Jan 15, 2026, 12:05 PM EST - 2 months ago

Boston Scientific Corporation (BSX) M&A Call Transcript

Jan 15, 2026, 11:03 AM EST - 2 months ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN)

Jan 15, 2026, 9:11 AM EST - 2 months ago

Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach

PEN

Jan 15, 2026, 8:45 AM EST - 2 months ago

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion.

PEN

Jan 15, 2026, 8:11 AM EST - 2 months ago

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing' vascular segments

PEN

Jan 15, 2026, 7:19 AM EST - 2 months ago

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

PEN

Jan 15, 2026, 7:07 AM EST - 2 months ago

Boston Scientific to buy Penumbra in deal valued at $14.5 billion

PEN

Jan 15, 2026, 7:00 AM EST - 2 months ago

Boston Scientific announces agreement to acquire Penumbra, Inc.

PEN

Jan 13, 2026, 3:55 PM EST - 2 months ago

Boston Scientific Corporation (BSX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 7:00 AM EST - 2 months ago

Boston Scientific Announces Agreement to Acquire Valencia Technologies Corporation

Jan 2, 2026, 8:00 AM EST - 2 months ago

Boston Scientific announces participation in the J.P. Morgan Healthcare Conference and conference call discussing fourth quarter and full year 2025 results

Dec 28, 2025, 2:40 AM EST - 2 months ago

Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside

Dec 2, 2025, 4:23 PM EST - 3 months ago

Boston Scientific Corporation (BSX) Presents at Citi Annual Global Healthcare Conference 2025 Prepared Remarks Transcript

Nov 18, 2025, 11:48 AM EST - 4 months ago

Boston Scientific Corporation (BSX) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript

OfficialStocktwitsUser Mar. 14 at 2:31 AM

0 · Reply

DragonAlgo Mar. 13 at 9:27 PM

0 · Reply

TheBurnerAccount Mar. 13 at 6:45 PM

$BSX Today may just be opex movement. Will know next week if its holding or not before the all clear

0 · Reply

amberajax2point0 Mar. 13 at 6:32 PM

$BSX too early to tell, but she is finally showing some life.

0 · Reply

Charterdi3 Mar. 13 at 4:30 PM

$BSX $DJT $UNH Nothing at all … 😛☺️ 3month charts ‼️

0 · Reply

DragonAlgo Mar. 13 at 4:45 AM

0 · Reply

REDBEAR Mar. 13 at 2:45 AM

$BSX reminds me of when I made a ton of money with $REGN going down. We will do the same here.

0 · Reply

GSTX7 Mar. 12 at 11:14 PM

$BSX Raise your hand if you're waiting for $60 to enter. 🙋

1 · Reply

TechTraderGrok Mar. 12 at 8:50 PM

0 · Reply

Bazzzigar Mar. 12 at 6:06 PM

$BSX few more

0 · Reply

DragonAlgo Mar. 12 at 5:25 PM

🐉 $BSX PUT — DragonAlgo® Signal Contract: BSX PUT Expiry: 2026-03-20 | Strike: $70.00 | Type: PUT Option Plan (premium): Entry: $2.67 Stop: $1.93 TP1: $3.48 TP2: $4.55 TP3: $6.42 Momentum tape remains active. 🔗 https://dragonalgo.com

0 · Reply

REDBEAR Mar. 12 at 4:25 PM

$TEM $RBLX $KKR $HUM $BSX duol nke cmg lulu this is my watchlist for next set of plays. I only want to trade the best names. Not junk 💩

3 · Reply

IncognitoBull Mar. 12 at 4:23 PM

$NMTC Rosa mentioned $BSX again. They paid a lot of money for Relievant. BS knows the market is there. They will not want a competitor in the space, especially if ours is better. They will want ours

3 · Reply

TheBurnerAccount Mar. 12 at 4:13 PM

$BSX 35 analysts and every one of them is a buy with the minimum target at $83, which is over 22% higher. Yet its a nonstop free fall. Fckn hell man. Obviously the iran war and AI means people dont need heart procedures...got it

0 · Reply

TheWolfOfSanFran Mar. 12 at 3:25 PM

$BSX keep going

0 · Reply

Jenshobby Mar. 12 at 3:00 PM

$BSX BSX Lawsuit Alleges Claims Executives Misrepresented U.S. Electrophysiology Volumes - BOSTON SCIENTIFIC CORPORATION Investors Face Losses Following Claims Executives Misrepresented U.S. Electrophysiology Volumes: SueWallSt

0 · Reply

jewell69 Mar. 12 at 12:50 PM

$BSX 75.50 minus 69.63 is a 7.77% decline after it totally fell out of bed and fell to 75.50 on 2/4 with an earnings beat of .80 vs .779 expected. 2/3 close 91.64 what's wrong here ? Is somebody cleaning their clock with a better stent ?

2 · Reply

Bazzzigar Mar. 12 at 12:08 AM

$BSX kick out the CEO

0 · Reply

DragonAlgo Mar. 11 at 11:57 PM

🐉 $BSX CALL — DragonAlgo® Signal Contract: BSX CALL Expiry: 2026-03-27 | Strike: $70.00 | Type: CALL Option Plan (premium): Entry: $2.08 Stop: $1.49 TP1: $2.70 TP2: $3.53 TP3: $4.98 🔗 https://dragonalgo.com

0 · Reply

PolycarpFX Mar. 11 at 9:01 PM

If 56 breaks cleanly there is risk down to 52 for the Med Device ETF $IHI Saw several dark pool prints hit for holdings within it today $ABT $BSX

0 · Reply

NewsAndFilings Mar. 11 at 7:16 PM

Medical Alert $BSX, $TFX, $ARAY, $CSDX, $NDRA Highlight Growing Hydrogel Tissue Spacer Market in Radiation Oncology https://thestreetreports.com/medical-alert-bsx-tfx-aray-csdx-ndra-highlight-growing-hydrogel-tissue-spacer-market-in-radiation-oncology/

0 · Reply

erevnon Mar. 11 at 3:53 PM

Citigroup maintains Boston Scientific $BSX at Buy and lowers the price target from $102 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Market Cap	102.58B
Revenue (ttm)	20.07B
Net Income (ttm)	2.90B
EPS (ttm)	N/A
PE Ratio	22.67
Forward PE	19.84
Profit Margin	14.44%
Debt to Equity Ratio	0.47

Volume	11,660,800
Avg Vol	15,621,056
Day's Range	N/A - N/A
Shares Out	1.48B
Stochastic %K	18%
Beta	0.69
Analysts	Strong Sell
Price Target	$106.52